GLAUCOMA 360

Ahmara Gibbons Ross, MD, PhD (University of Pennsylvania) and Sunita Radhakrishnan, MD (Glaucoma Center of San Francisco) discuss new non-IOP-lowering glaucoma treatments in the pipeline (in development, but not yet ready for use by glaucoma patients). These innovative new approaches to glaucoma treatment include neuroenhancement, neuroregeneration, and neuroprotection as a new way to prevent vision loss and potentially even restore lost vision in glaucoma patients. Ahmara and Sunita co-moderated the session on Non-IOP Lowering Glaucoma Treatments at New Horizons Forum in San Francisco on February 7, 2020. Website: glaucoma360.org

Christy Shaffer, PhD was co-moderator of the session "Show Me The Money — Getting to Go in Early Stage Glaucoma Financing" at the 9th Annual Glaucoma 360 New Horizons Forum on February 7, 2020 in San Francisco. In this video interview with Glaucoma Research Foundation, she discusses the process of taking an idea from an academic environment to a new solution for helping glaucoma patients. Website: glaucoma360.org

We interviewed Inder Paul Singh, MD (The Eye Centers of Racine and Kenosha) about "New Devices in Glaucoma" at the Glaucoma 360 New Horizons Forum in San Francisco on February 7, 2020. Dr. Singh discusses the benefits of new laser treatments such as SLT and new MIGS (Micro-Invasive Glaucoma Surgery) options for early intervention in glaucoma treatment. Glaucoma 360 is presented annually by Glaucoma Research Foundation, a nonprofit organization based in San Francisco, CA. Website: glaucoma360.org

Thurein Htoo, MS, MBA, CEO of Qlaris Bio, Inc. presents at the Glaucoma 360 New Horizons Forum in San Francisco, CA on February 7, 2020 during the session "Show Me The Money - Getting to Go in Early Stage Glaucoma Financing." New Horizons Forum is presented annually by Glaucoma Research Foundation in San Francisco. Website: glaucoma360.org

Oluwatosin Smith, MD (Glaucoma Associates of Texas) co-moderated the 2020 New Horizons Forum industry panel discussion on glaucoma pharmaceuticals. In this exclusive interview with Glaucoma Research Foundation, Dr. Tosin Smith discusses the main takeaway messages from the session at Glaucoma 360 in San Francisco, and her vision for the future of pharmaceutical treatments for glaucoma.

Adrienne Graves, PhD is co-chair and co-founder of Glaucoma 360 (along with Andrew Iwach, MD). In this video, Dr. Graves gives the welcome and opening remarks at the 9th Annual Glaucoma 360 - New Horizons Forum in San Francisco on February 7, 2020 at the Grand Hyatt San Francisco. Website: glaucoma360.org